← Back to Dictionary
Wellness
PT-141 (Bremelanotide)
Molecular Weight
1025.18 Da
Half-Life
~2-4 hours
Dosing Protocol
0.5-2 mg subcutaneous as needed
Key Benefits
Libido enhancementCentral nervous system mechanismWorks for both sexesFDA-approved (Vyleesi)
Mechanism of Action
Melanocortin receptor 4 agonist acting centrally in the nervous system rather than peripherally on vasculature.
Research Summary
FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. Clinically validated mechanism.
Stacks Well With